Search Results - "METCALF, John S"

Refine Results
  1. 1
  2. 2
  3. 3

    Blue Nevus & “Malignant Blue Nevus:” A Concise Review by Sugianto, Jessica Zarah, M.D, Ralston, Jonathan Scott, M.D, Metcalf, John S., M.D, McFaddin, Courtney L., M.D, Smith, M. Timothy, M.D

    Published in Seminars in diagnostic pathology (01-07-2016)
    “…Abstract Blue nevi are a heterogeneous group of lesions that can display a variety of different clinicopathological characteristics. Although attempts are made…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Quantitative real‐time RT‐PCR detection of breast cancer micrometastasis using a multigene marker panel by Mitas, Michael, Mikhitarian, Kaidi, Walters, Christian, Baron, Paul L., Elliott, Bruce M., Brothers, Thomas E., Robison, Jay G., Metcalf, John S., Palesch, Yuko Y., Zhang, Zhen, Gillanders, William E., Cole, David J.

    Published in International journal of cancer (15-07-2001)
    “…Real‐time RT‐PCR is a relatively new technology that uses an online fluorescence detection system to determine gene expression levels. It has the potential to…”
    Get full text
    Journal Article
  7. 7

    Merkel cell carcinoma in situ by Ferringer, Tammie, Rogers, Hudson C., Metcalf, John S.

    Published in Journal of cutaneous pathology (01-02-2005)
    “…Background:  Merkel cell carcinoma (MCC) is a dermal small blue‐cell tumor that occurs in the elderly on the sun damaged head and neck. Epidermal involvement…”
    Get full text
    Journal Article
  8. 8

    Radiation therapy for B-cell cutaneous lymphoid hyperplasia by Taylor, Robert B., Fortney, John A., Pollack, Ross B., Metcalf, John S., Jenrette, Joseph M.

    Published in Japanese Journal of Radiology (01-06-2010)
    “…Recent work has demonstrated that B-cell cutaneous lymphoid hyperplasia (BCCLH) lies in a spectrum of B-cell lymphoproliferative disorders that can progress to…”
    Get full text
    Journal Article
  9. 9

    TRAF3-interacting protein 3, a new oncotarget, promotes tumor growth in melanoma by Nasarre, Patrick, Bonilla, Ingrid V, Metcalf, John S, Hilliard, Eleanor G, Klauber-DeMore, Nancy

    Published in Melanoma research (01-06-2018)
    “…TRAF3-interacting protein 3 (TRAF3IP3) is expressed in the immune system and participates in cell maturation, tissue development, and immune response. In a…”
    Get full text
    Journal Article
  10. 10

    An Innovative Microarray Strategy Identities Informative Molecular Markers for the Detection of Micrometastatic Breast Cancer by MIKHITARIAN, Kaidi, GILLANDERS, William E, ALMEIDA, Jonas S, MARTIN, Renee Hebert, VARELA, Juan C, METCALF, John S, COLE, David J, MITAS, Michael

    Published in Clinical cancer research (15-05-2005)
    “…There is increasing evidence that molecular detection of micrometastatic breast cancer in the axillary lymph nodes (ALN) of breast cancer patients can improve…”
    Get full text
    Journal Article
  11. 11

    Langerhans cell sarcoma by FERRINGER, Tammie, BANKS, Peter M, METCALF, John S

    Published in The American journal of dermatopathology (01-02-2006)
    “…Proliferations of Langerhans cells can be histologically divided into cytologically benign Langerhans cell proliferations, which include the clinical syndromes…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Histologic patterns of polyethylene glycol-liposomal doxorubicin-related cutaneous eruptions by CADY, Francois M, KNEUPER-HALL, Rayna, METCALF, John S

    Published in The American journal of dermatopathology (01-04-2006)
    “…Polyethylene glycol (PEG)-liposomal doxorubicin (Stealth R, Doxil) is a formulation of doxorubicin, which is encapsulated in liposomes formulated with PEG. It…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: Results of a multi-institutional prospective cohort study by Mikhitarian, Kaidi, Martin, Renee Hebert, Mitas, Michael, MIMS Study Group, Mauldin, Patrick D., Palesch, Yuko, Metcalf, John S., Cole, David J., Gillanders, William E.

    Published in Surgery (01-09-2005)
    “…Pathologic evaluation may lack the sensitivity required for accurate staging of the axilla in breast cancer patients. We have completed enrollment of a…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Melanoma thickness and histology predict sentinel lymph node status by Nguyen, Christophe L, McClay, Ed F, Cole, David J, O’Brien, Paul H, Gillanders, William E, Metcalf, John S, Maize, John C, Baron, Paul L

    Published in The American journal of surgery (2001)
    “…Background: It remains unclear which patients with melanoma will benefit most from lymphatic mapping and sentinel lymphadenectomy. The purpose of this study is…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel by Lockett, Mark A, Baron, Paul L, O’Brien, Paul H, Elliott, Bruce M, Robison, Jacob G, Maitre, Nathalie, Metcalf, John S, Cole, David J

    “…Background: Axillary lymph node status in breast cancer patients remains the single most important predictor of outcomes. Current methods of histopathologic…”
    Get full text
    Journal Article